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ABSTRACT 
Background 
Enhanced Recovery After Surgery (ERAS) reduces complications and hospital stay in 
colorectal surgery. Thereafter, ERAS principles were extended to liver surgery. Previous 
implementation of an ERAS program in colorectal surgery may influence patients undergoing 
liver surgery in a non-ERAS setting, on the same ward.  This study aimed to test this 
hypothesis.  
Methods 
Retrospective analysis based on prospective data of the adherence to the institutional ERAS-
liver protocol (compliance) in 3 cohorts of consecutive patients undergoing elective liver 
surgery, between June 2010 and July 2014: before any ERAS implementation (pre-ERAS n = 
50), after implementation of ERAS in colorectal (intermediate n=50), and after implementation 
of ERAS in liver surgery (ERAS-liver n=74). Outcomes were functional recovery, postoperative 
complications, hospital stay, and readmissions.  
Results 
The 3 groups were comparable for demographics; laparoscopy was more frequent in ERAS-
liver (p=0.009). Compliance with the enhanced recovery protocol increased along the 3 periods 
(pre-ERAS, intermediate and ERAS-liver), regardless of the perioperative phase (pre-, intra- or 
post-operative). ERAS-liver group displayed the highest overall compliance rate with 73.8%, 
compared to 39.9% and 57.4% for pre-ERAS and Intermediate groups (p=0.072/0.056). Overall 
complications were unchanged (p=0.185), whereas Intermediate and ERAS-liver groups 
showed decreased major complications (p=0.034). Consistently, hospital stay was reduced by 2 
days (p=0.005) without increased readmissions (p=0.158). 
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Conclusions 
The previous implementation of an ERAS protocol in colorectal surgery may induce a positive 
impact on patients undergoing non-ERAS liver surgery on the same ward. These results 
suggest that ERAS is safely applicable in liver surgery, and associated with benefits. 
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INTRODUCTION 
Enhanced recovery (ERAS) pathways have become standard of care in colorectal surgery due 
to significant reduction of complications, length of stay (LoS) and costs 1-5. As a result, ERAS 
protocols were subsequently extended to other types of surgery, including gastric 6, pancreatic 7 
and liver 8 surgery. The use of ERAS protocols in liver surgery appeared to be safe and feasible 
9-11. However, applied protocols widely varied and the assessment of their application 
(compliance) was rarely reported. Moreover, some ERAS protocols in liver surgery were 
implemented in centers having an institutional experience of ERAS in colorectal surgery. The 
previous implementation of ERAS in colorectal surgery presumably influence other types of 
surgery performed in a non-ERAS setting, provided the patients are on the same ward and 
treated by the same anesthetists. The usual comparative group “pre-ERAS” may thus be biased 
by this influence. It may be hypothesized that this impact could be observed in different 
protagonists: patients and medical staff. Regarding the patients, non-ERAS ones may be 
influenced by observing early feeding and mobilization in ERAS patients, then requesting 
similar care. Likewise, surgeons, anesthetists and nurses potentially modify their management 
of non-ERAS patients, according to ERAS principles. 
The present study aimed to test this hypothesis by analyzing the compliance and the clinical 
outcomes of patients undergoing elective liver surgery in 3 different groups: before institutional 
ERAS implementation for colorectal surgery (pre-ERAS), after ERAS implementation for 
colorectal but before its application for liver surgery (intermediate), and after the implementation 
of ERAS in liver surgery (ERAS-liver). 
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METHODS 
Enhanced recovery after surgery program (ERAS) for colorectal surgery was implemented in 
our institution in May 2011 in a systematic manner as recommended by ERAS Society 
guidelines12. Then, ERAS was implemented in liver surgery in July 2013, by the same 
multidisciplinary team, in the same ward, with the same method13 applying an institutional 
formal ERAS-liver protocol. Documentation of adherence to the ERAS pathway (compliance) is 
key component of ERAS program, and was therefore systematically measured for all patients. 
Systematic comparison with patients before, during, and after implementation was performed 
and is detailed below. The Institutional Review Board approved the study and all patients 
provided written consent before surgery. The study was conducted in accordance with the 
STROBE criteria (http://strobe-statement.org/) and registered under www.researchregistry.com 
(UIN: 392). 
 
Patients 
The implementation of ERAS program for colorectal surgery may presumably influence 
perioperative care for liver resections. To test this hypothesis, 3 groups of patients were 
analysed: “Pre-ERAS”, “Intermediate” and “ERAS-liver”, as illustrated in Figure 1. Each group 
was a cohort of consecutive patients undergoing elective liver surgery. “Pre-ERAS” patients 
were included before implementation of any ERAS in colorectal surgery. “Intermediate” included 
patients after implementation for colorectal but before implementation of ERAS for liver 
resection. “ERAS-liver” included patients after implementation of the specific ERAS-liver 
protocol. Of note, no exclusion criteria were applied. Therefore, all consecutive patients were 
included, regardless of the age or any other parameter. 
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ERAS protocol and compliance (Table 1) 
To date, no validated guidelines for enhanced recovery in liver surgery have been published by 
the ERAS Society. The present specific ERAS protocol for liver surgery was created by our 
team and adapted from the enhanced recovery pathway for colorectal surgery, published 14,15, 16  
by the ERAS Society, and from the published pancreas ERAS guidelines 17. ERAS was 
implemented in our institution for colorectal and pancreatic surgeries in May 2011 and 
September 2013, respectively. Additional specific items related to liver surgery were adapted, 
based on available evidence. Table 1 provides a comprehensive overview of our enhanced 
recovery protocol for liver surgery with the respective references. Compliance with the ERAS 
protocol was prospectively assessed for the different phases of perioperative care (pre-, intra- 
and post-operative). Briefly, enhanced recovery items were handled as dichotomous variables. 
Individual adherence to the protocol was calculated as percentage of compliant patients/total 
patients. The number of fulfilled items divided by the total number of enhanced recovery 
measures (%) is presented as overall compliance with the pathway. 
 
Data collection 
A dedicated trained ERAS nurse was in charge of completing the prospective database. 
Demographic and surgical details of all patients in the enhanced recovery pathway were 
captured along with detailed information on compliance with the protocol and audit of clinical 
outcome with a minimal follow-up of 30 postoperative days. Control of pain with oral analgesia 
only, stop of intravenous fluid, full mobilization and eating solid food were recorded, while 
postoperative complications were graded according to Clavien classification 18 and to the 
Comprehensive Complication Index (CCI) 19. CCI is a score that integrates and sum all 
postoperative complications with their respective severity, on a scale ranging from 0 (no 
complication) to 100 (death); underreporting of minor complications can thus be avoided and 
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reporting of complication is supposed to be more accurate19. Length of stay was counted from 
day of surgery until discharge. Discharge was decided on pre-established criteria: control of 
pain with oral analgesia, eating solid food, return of bowel function, full mobilization. 
Readmissions were considered within 30 days after surgery. 
Statistics 
Descriptive statistics for categorical variables were reported as frequency (%), while continuous 
variables were reported as median (interquartile range). Continuous variables were compared 
between “pre-ERAS”, “Intermediate” and “ERAS-liver” groups with the Kruskal Wallis test. Chi-
square was used for comparison of categorical variables. All statistical tests were two-sided and 
a level of 0.05 was used to indicate statistical significance. Data analyses were performed using 
SPSS v20 statistical software, Chicago, IL. 
 
RESULTS 
Patients 
Seventy-four patients who underwent liver surgery in the “ERAS-liver” group were compared to 
50 patients in the “pre-ERAS” group, and 50 patients in the “intermediate” group. Baseline 
demographics were similar between the 3 groups (Table 2). Patients in the ERAS-liver group 
had more laparoscopic procedures than the comparative groups (4.1% vs. 14% vs. 24.7%) 
(p=0.009), and less pedicular clamping (68%, 28%, 39.2%, p<0.001). The characteristics of 
surgery are detailed in table 3. 
 
ERAS implementation and compliance with the protocol 
Compliance with the enhanced recovery pathway steadily increased along the 3 periods (pre-
ERAS, intermediate and ERAS-liver), regardless of the perioperative phase (pre-, Intra- or post-
operative). While intra-operative phase globally displayed the highest compliance rate, pre-
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operative and postoperative items were the most influenced by the implementation of an ERAS 
pathway (Figure 2).  
  
Figure 3 illustrates each ERAS items displaying a significant difference across the groups, in 
term of compliance rate (all ERAS items are detailed in Appendix 1). Regarding preoperative 
phase, ERAS-liver group displayed greater compliance rate for each item, with a mean rate of 
81.1%, comparing to 32.2% and 4.5% in intermediate and pre-ERAS groups, respectively 
(P<0.001). A significant difference was highlighted in 3 intraoperative items: avoidance of 
nasogastric tube (p<0.001), PONV prophylaxis (p<0.001) and the use of pneumatic boots 
(p<0.001). ERAS implementation showed a significant impact on postoperative phase, with 
most items showing statistical differences between the studied groups: balanced IV fluid at 
POD 0 (p<0.001), start of intake water and free fluids at POD 0 (p<0.001), mobilization at POD 
0 (p=0.04), oral analgesia at POD 1 (p<0.001), normal diet at POD 1 (p<0.001), full mobilization 
at POD1 (p=0.015), UC removal at POD 3 (p=0.019) and stop epidural/intravenous analgesia at 
POD4 (p=0.001).  
 
Functional recovery (Figure 4) 
The duration of intravenous or subcutaneous analgesia in liver patients was reduced after both 
implementations of ERAS in colorectal (p=0.001) and liver surgery (p<0.001). Discontinuation of 
intravenous fluid (p=0.016) and full mobilization (p=0.023) were mostly influenced by the 
institutional implementation of ERAS for colorectal surgery. Regarding intake of solid food, the 3 
compared groups did not display any difference (p=0.093). Likewise, the postoperative 
normalization of serum bilirubin remained comparable across the groups (p=0.137) (data not 
shown). 
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Complications, length of stay (Table 4) 
Overall postoperative morbidity did not differ between the comparative groups and is 
summarized in detail in Table 4. However, intermediate and ERAS-liver groups showed a 
significant reduction of major complications in comparison to pre-ERAS group (10% and 13.5% 
vs 28%, respectively; p=0.034). Consistently, hospital stay was significantly reduced by about 
two days in intermediate and ERAS-liver groups (10.5, 8.5, 8 days, p=0.005), without increasing 
readmission rate (2%, 12%, 8.1%, p=0.158). Furthermore, introduction of ERAS permitted 
shorter stays within Intensive Care (3 vs. 2 vs. 2 nights, p=0.001) and Intermediate Care Units 
(1 vs. 0 vs. 0 night) (p<0.001) with similar admission and discharge criteria.  
 
DISCUSSION 
To the best of our knowledge, the collateral impact of an ERAS program implementation on a 
non-ERAS specialty within the same department – supported by a thorough assessment of the 
compliance-may have been suspected, but was measured for the first time herein. The present 
findings suggest that the previous implementation of an ERAS pathway in colorectal surgery 
had a positive collateral impact on patients undergoing liver surgery in a non-ERAS program. In 
addition, the present results also confirm that ERAS pathway is applicable and associated with 
benefits, in liver surgery. 
After the successful implementation of ERAS in colorectal surgery, some enhanced recovery 
items were “unconsciously” introduced and applied in patients undergoing liver surgery in a 
non-ERAS setting. After the systematic application of a specific liver protocol, compliance was 
further increased along with improvements of both functional and clinical outcomes. Liver 
metastases from colorectal cancer represent an important indication for liver resection in the 
present series. However, the majority of patients with synchronous colorectal liver metastasis 
underwent “liver first” approach20, whereas most patients referred from other centers 
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experienced surgery for the primary colorectal tumor, in a non-ERAS setting. As a result, only 9 
patients (12%) of the group ERAS-Liver were previously operated in a formal ERAS-colorectal 
setting. This limited subset of patients is unlikely to be the only cause of the increased 
compliance observed after ERAS implementation. 
Strikingly, the results of this study give rise to two major concepts: (I) the landscape of the 
benefits associated with the implementation of ERAS in colorectal surgery is redrawn and (II) 
the role of randomized trials addressing the effect of ERAS may be questioned. Regarding the 
former, it was already established that the implementation of ERAS in colorectal surgery had a 
positive impact on patients with reduced complications and LoS1-5. In addition, ERAS in 
colorectal surgery was also proven to be cost-effective13. Importantly, this present study 
demonstrates a broader interest of implementing ERAS in colorectal surgery, since it seems to 
also positively influence patients undergoing other types of surgery, provided they are located 
on the same ward. Therefore, the present findings are challenging the role of prospective 
clinical studies to address to effect of ERAS, since the control group (non-ERAS) is at risk to be 
biased by the previous institutional implementation of ERAS, like the intermediate group in the 
present study. Blind trials comparing enhanced recovery and traditional care are not a realistic 
option (drain vs. no drain, bed rest vs. early mobilization or, early feeding vs. traditional 
postoperative fasting until bowel recovery, etc.). So either prospective randomized study should 
be conducted in different hospitals and different teams, or enhance recovery programs should 
be compared with historical cohorts; both designs display intrinsic limitations. 
Monitoring compliance is particularly crucial in enhanced recovery program since it determines 
whether the protocol is actually applied 21, 22. Comparison with other published studies is 
somehow awkward for two reasons:  high heterogeneity of protocols, and rarely reported 
compliance with the applied protocol. As a consequence, some negative reported results on 
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recovery programs may presumably be due to a low compliance with the protocol rather than to 
a failure of the recovery protocol itself.  
Furthermore, as no validated ERAS protocol has been published yet for liver surgery, a variety 
of heterogeneous ERAS-liver protocols has been applied and published 23. In comparison with 
other published protocols, the present one was stricter for food intake (normal diet at POD 1) 
and mobilization (full mobilization at POD 1). Conversely, it was more conservative for urinary 
catheter removal (POD 3, instead of POD 1-2)11, 23, 24. Most reported studies were designed to 
analyse outcomes, rather than compliance 9, 10, 25. Of note, the compliance rate measured in 
this present study was higher than in other studies 23, 26. As an example, the avoidance of 
nasogastric tube and abdominal drain was achieved in 97.3% and 54.1% respectively, while a 
recently published multicentric study reported 53% and 41%, respectively23.  
Comparable to compliance, functional recovery substantially differed between studies. Although 
several studies supported the positive impact of enhanced recovery pathway on recovery, they 
did not thoroughly analyse functional recovery following liver surgery8, 9, 24. In this regard, the 
present results showed an improvement of pain control, duration of intravenous fluid and full 
mobilization, after liver ERAS implementation. Consistently with previous reports, a reduced 
length of stay without any increasing in readmission rate was observed8-10. It may be 
hypothesized that this effect is due to the enhanced recovery protocol itself, or to the 
systematisation of perioperative management based on clinical pathway; this is however 
beyond the scope of the present study and deserves further investigations.  
Regarding shorter length of stay8, 10, 27, 28, this reduction could result from reduced 
complications. However, comparing LoS between different countries with different healthcare 
systems is often biased, the most important factor being the reduction in LoS after the 
introduction of a recovery program, rather than its absolute value.   
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The analysis of the overall morbidity –using the Comprehensive Complication Index (CCI) – 
showed a median value of 8.7 in ERAS-Liver, while CCI reached 20.9 for both pre-ERAS and 
intermediate groups, which was however not significant (p=0.185).   
With a design including 3 comparative groups along ERAS implementation, this present study 
was able to measure the unique aspect of an intermediate group after ERAS colorectal but 
before ERAS liver.   
Several limitations of the present study have to be addressed. Although the 3 compared groups 
were similar for most studied variables, ERAS group displayed higher rate of laparoscopic 
procedures (p=0.009) and less inflow clamping (p<0.001). This probably reflects the current 
evolution of liver surgery, with the extension of non-invasive techniques. This difference may 
partially explain the better outcome observed in ERAS-liver, notably the reduced LoS. Although, 
laparoscopic surgery was increasingly performed over time, its indication was limited to left 
lateral sectionectomy or anterior wedge resection, thus minimizing its effect on the overall LoS. 
A potential bias effect can however not be completely excluded25. Of note, Stoot et al. have 
showed that enhanced recovery pathway may also be beneficial in laparoscopic liver surgery; 
laparoscopy may thus be regarded as a constitutive item of enhance recovery. In addition -
although the data were collected in a prospective database- its retrospective analysis is 
associated with intrinsic limitations. 
 
In conclusion, the present study suggests that the implementation of an ERAS protocol 
for colorectal surgery induces a positive collateral impact on non-ERAS liver surgery patients, 
provided they are located on the same ward and treated by the same team. Moreover, these 
results confirm that ERAS-liver pathway is applicable and beneficial in liver surgery with 
significantly enhanced functional recovery and reduced LoS, without impairing morbidity or 
readmission.  
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Table 1:  The institutional enhanced recovery pathway for colorectal and liver surgery 
Item Colorectal     Liver               Ref 
 
Pre-operative items 
Preoperative counselling  Preadmission counseling   Same    15
 and written information 
 
Bowel preparation Avoidance of bowel preparation   Not relevant    
 
Fasting Clear fluids until 2h before    Same    29 
surgery, solids 6h before surgery 
 
Carbohydrate drinks 800 ml the evening before surgery  Same    16 
and 400 ml 2h before surgery 
 
Immunonutrition (IN) IN could be considered in open    Same    30 
 colonic resections 
 
Premedication No pre-operative long-acting sedative  Same    16 
 premedication 
 
Thromboprophylaxis LMW heparin 12h before surgery, IPC  Same    31 
 
Intra-operative items 
Antibiotic prophylaxis Cefuroxime 1.5g+metronidazole 500,  Cefuroxime 1.5g,    32 
 30min before incision    30min before incision 
 
Hypothermia prevention Active warming with air blanket   Same     
 
PONV prophylaxis Droperidol 1mg at induction, ondansetron  Same    33 
 4 mg ± betamethasone 4mg at the end of surgery 
 
Post-operative items 
Balanced IV fluids Intraoperative cristalloid quantity depending  Goal directed fluid therapy with 34 
 on the operation avoiding salt and water overload. low CVP during liver 
 Postoperative cristalloids 1000 ml for the first 24h  resection, restoration of euvolemia 
 then 500 ml/24h for the first postoperative days after the resection. 
 
Postoperative analgesia Epidural or PCA removed after 48h.  Paracetamol, metamizole,  15 
 Paracetamol, ibuprofen, and oxycodone-  Epidural removed on POD 4  
 Naloxone only for breakthrough pain  and switch to oral opioids 
 
Abdominal drains No routine abdominal drainage   Same    35 
 
Nasogastric tube No routine postoperative use  Same    36 
 
Urinary catheter Removal on POD 1    Removal on POD 3  16 
 
Nutrition Free fluids 4h after surgery. Normal diet   Free fluids 4h after surgery.  16 
 from day of surgery. Two nutritional   Normal diet on POD 1. Two 
   supplements (300 kcal/unit) per day.  Nutritional supplements per day 
 
Laxatives Oral magnesium hydroxide ± chewing gum  Same 
 
Mobilization Out of bed more than 15 min on day of surgery, Same     37 
 at least 6h per day thereafter.   
 
Systematic audit Systematic audit, meeting every 2 weeks.  Ongoing implementation  21 
 
LMW: low molecular weight, IPC: intermittent pneumatic compression, PONV: postoperative nausea and vomiting, PCA: patient-
controlled analgesia, POD: postoperative day. 
ª Betamethasone only for women or non-smokers or those with previous history of PONV. 
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Table 2:  Patients’ characteristics  
 
 
 
 
Pre-ERAS 
(n=50) 
Intermediate 
(n=50) 
ERAS-liver 
(n=74) 
P 
value 
Age (years) * 64 (59-69) 64 (57-73) 60 (49.75-68) 0.073 
Sex ratio, (M:F) 35:15 25:25 43:31 0.122 
Body mass index (kg/m2) * 24.8 (23.3-27.8) 24.5 (21.4-27.5) 25.3 (21.6-29) 0.749 
ASA grade §    0.77 
I-II, n (%) 36 (72%) 35 (70%) 56 (75.7%)  
III-IV, n (%) 14 (28%) 15 (30%) 18 (24.3%)  
Cirrhosis n, (%) § 6 (12%) 6 (12%) 4 (5.4%) 0.33 
Smoker n, (%) § 9 (18%) 10 (20%) 16 (21.6%) 0.885 
Diabetes n, (%) § 13 (26%) 6 (12%) 13 (17.6%) 0.19 
Diagnosis §    0.425 
Neoplasia, n (%) 43 (86%) 44 (88%) 55 (74.3%) 0.099 
HCC, n (%) 6 (12%) 10 (20%) 10 (13.5%)  
Cholangiocarcinoma, n (%) 2 (4%) 7 (14%) 9 (12.2%)  
Metastasis, n (%) 25 (50%) 21 (42%) 31 (41.9%)  
Echinococcosis, n (%) 5 (10%) 2 (4%) 11 (14.9%)  
Benign lesions 2 (4%) 3 (6%) 5 (6.8%)  
Others 10 (20%) 7 (14%) 8 (10.8%)  
Values are median (IQR). § Chi-square test, * Kruskal Wallis 
ASA, American Society of Anesthesiologists. HCC: Hepatocellular Carcinoma. Additional procedure: 
cholecystectomy was not included. Major resection: ≥3 resected segments. Minor resection: <3 resected 
segments. 
 
 
 
 
 
 
 
 
 
 
 
21 
 
Table 3:  Types of surgery 
 
 
 
 
 
Pre-ERAS 
(n=50) 
Intermediate 
(n=50) 
ERAS-Liver 
(n=74) 
P 
value 
 
Surgical approach §  
 
 0.009 
Laparoscopic, n (%) 2 (4.1%) 7 (14%) 18 (24.7%)  
Open, n (%) 47 (95.9%) 43 (86%) 55 (75.3%)  
Procedure §    0.914 
    Major resection, n (%) 22 (44%) 21 (42%) 30 (41.1%)  
    Minor resection, n (%) 27 (54%) 29 (58%) 43 (58.9%)  
    Anastomosis, n (%) 4 (8.2%) 5 (10%) 11 (14.9%) 0.481 
    Clamping, n (%) 34 (68%) 14 (28%) 29 (39.2%) <0.001 
Values are median (IQR). § Chi-square test, * Kruskal Wallis 
ASA, American Society of Anesthesiologists. HCC: Hepatocellular Carcinoma. Additional procedure: 
cholecystectomy was not included. Major resection: ≥3 resected segments. Minor resection: <3 resected 
segments. 
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Table 4: Complications and hospital stay  
 
   
 
Pre-ERAS 
(n=50) 
Intermediate 
(n=50) 
ERAS-Liver 
(n=74) 
P 
value 
 
30d complications (No. of patients, %)§  
 
  
overall 30 (60%) 33 (66%) 37 (50.7%) 0.224 
I-II, n (%) 25 (50%) 31 (62%) 36 (48.6%) 0.306 
III-IV, n (%) 14 (28%) 5 (10%) 10 (13.5%) 0.034 
V, n (%) 0 (-) 2 (4%) 1 (1.4 %) 0.291 
CCI * 20.9 (0-31.5) 20.9 (0-25.6) 8.7 (0-21.3) 0.185 
Hospital stay (days)* 10.5 (8-17) 8.5 (6.75-14.25) 8 (6-11) 0.005 
Nights in ICU * 3 (2-5) 2 (1-4) 2 (1-3.25) 0.001 
Nights in IC * 1 (0-2) 0 (0-1) 0 <0.001 
30d re-admissions, n (%)§ 1 (2%) 6 (12%) 6 (8.1%) 0.158 
Values are median (IQR), §Chi-square test, *Kruskal Wallis. 
POD: Postoperative day. CCI: Comprehensive Complications Index. ICU: Intensive Care Unit. IC: Intermediate 
Care. 
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